- Friday, October 1, 2021
9:00 AM – 9:25 AM EDT
Welcome and Opening Session: The State of Clinical Pathways: Journal of Clinical Pathways Benchmarking Survey
9:00 AM – 9:25 AM EDT
Welcome and Opening Session: The State of Clinical Pathways: Journal of Clinical Pathways Benchmarking SurveyPresenter: – W-Squared Group
Winston Wong, PharmD – W-Squared Group ### 797863###Presenter###President###W-Squared Group###Presenter: – W-Squared Group
9:25 AM – 9:55 AM EDT
Pathways in Integrated Delivery Systems - Part 1
9:25 AM – 9:55 AM EDT
Pathways in Integrated Delivery Systems - Part 1Presenter: – Kaiser Permanente
Presenter: – University of Texas, MD Anderson Cancer Center
Tatjana Kolevska, MD – Kaiser Permanente ### 1375988###Presenter###Medical Director, Kaiser Permanente National Cancer Excellence Program###Kaiser Permanente###Presenter: – Kaiser Permanente
@@@ Michael Wong, MD PhD FRCPC – University of Texas, MD Anderson Cancer Center ### 1417447###Presenter###Professor###University of Texas, MD Anderson Cancer Center###Presenter: – University of Texas, MD Anderson Cancer Center
10:10 AM – 11:10 AM EDT
Innovation Theater - The Treatment of CLL/SLL and WM with Imbruvica® (non-accredited)
10:10 AM – 11:10 AM EDT
Innovation Theater - The Treatment of CLL/SLL and WM with Imbruvica® (non-accredited)
11:25 AM – 11:55 AM EDT
Ask the Experts
11:25 AM – 11:55 AM EDT
Ask the ExpertsPresenter: – Michiana Hematology-Oncology, PC
Robin Zon, MD, FACP – Michiana Hematology-Oncology, PC ### 736521###Presenter###President###Michiana Hematology-Oncology, PC###Presenter: – Michiana Hematology-Oncology, PC
12:10 PM – 12:40 PM EDT
Pathways in Integrated Delivery Systems - Part 2
12:10 PM – 12:40 PM EDT
Pathways in Integrated Delivery Systems - Part 2Presenter: – Smilow Cancer Hospital and Yale Cancer Center
Presenter: – Advocate Aurora Health
Kerin Adelson, MD – Smilow Cancer Hospital and Yale Cancer Center ### 1004278###Presenter###Chief Quality Officer###Smilow Cancer Hospital and Yale Cancer Center###Presenter: – Smilow Cancer Hospital and Yale Cancer Center
@@@ James L. Weese, MD, FACS – Advocate Aurora Health ### 1367350###Presenter###Vice President, Aurora Cancer Care, ###Advocate Aurora Health###Presenter: – Advocate Aurora Health
12:40 PM – 1:10 PM EDT
Panel Q&A: Pathways in Integrated Delivery Systems
12:40 PM – 1:10 PM EDT
Panel Q&A: Pathways in Integrated Delivery SystemsPresenter: – Roswell Park Comprehensive Cancer Center
Presenter: – Smilow Cancer Hospital and Yale Cancer Center
Presenter: – Advocate Aurora Health
Presenter: – Kaiser Permanente
Presenter: – University of Texas, MD Anderson Cancer Center
Stephen B. Edge, MD, FACS, FASCO – Roswell Park Comprehensive Cancer Center ### 736514###Presenter###VP Healthcare Outcomes and Policy###Roswell Park Comprehensive Cancer Center###Presenter: – Roswell Park Comprehensive Cancer Center
@@@ Kerin Adelson, MD – Smilow Cancer Hospital and Yale Cancer Center ### 1004278###Presenter###Chief Quality Officer###Smilow Cancer Hospital and Yale Cancer Center###Presenter: – Smilow Cancer Hospital and Yale Cancer Center
@@@ James L. Weese, MD, FACS – Advocate Aurora Health ### 1367350###Presenter###Vice President, Aurora Cancer Care, ###Advocate Aurora Health###Presenter: – Advocate Aurora Health
@@@ Tatjana Kolevska, MD – Kaiser Permanente ### 1375988###Presenter###Medical Director, Kaiser Permanente National Cancer Excellence Program###Kaiser Permanente###Presenter: – Kaiser Permanente
@@@ Michael Wong, MD PhD FRCPC – University of Texas, MD Anderson Cancer Center ### 1417447###Presenter###Professor###University of Texas, MD Anderson Cancer Center###Presenter: – University of Texas, MD Anderson Cancer Center
1:25 PM – 2:10 PM EDT
Improving Survival and Managing Costs in NSCLC:
The Role of Clinical Care Pathways
1:25 PM – 2:10 PM EDT
Improving Survival and Managing Costs in NSCLC: The Role of Clinical Care PathwaysPresenter: – AdventHealth Medical Group
Mark Socinski, MD – AdventHealth Medical Group ### 1098567###Presenter###Executive Director, Thoracic Cancer###AdventHealth Medical Group###Presenter: – AdventHealth Medical Group
2:25 PM – 3:10 PM EDT
Measuring ROI on Standardized Clinical Pathways Utilization
2:25 PM – 3:10 PM EDT
Measuring ROI on Standardized Clinical Pathways Utilization Presenter: – The Center for Cancer and Blood Disorders
Ray Page, DO, PhD, FACOI, FASCO – The Center for Cancer and Blood Disorders ### 1004277###Presenter###President & Director of Research###The Center for Cancer and Blood Disorders###Presenter: – The Center for Cancer and Blood Disorders
3:25 PM – 4:25 PM EDT
Innovation Theater - BLENREP for Injection 100mg (non-accredited)
3:25 PM – 4:25 PM EDT
Innovation Theater - BLENREP for Injection 100mg (non-accredited)
4:40 PM – 5:10 PM EDT
Ask the Experts
4:40 PM – 5:10 PM EDT
Ask the Experts Presenter: – Harvard Business School
Mahek A. Shah, MD – Harvard Business School ### 736511###Presenter###Physician Executive and Advisor###Harvard Business School###Presenter: – Harvard Business School
5:25 PM – 6:10 PM EDT
Utilizing Pathways to Advance Equity in Cancer Care
5:25 PM – 6:10 PM EDT
Utilizing Pathways to Advance Equity in Cancer CarePresenter: – NantHealth, Inc.
Tiffany Avery, MD – NantHealth, Inc. ### 1393295###Presenter###Chief Medical Officer###NantHealth, Inc.###Presenter: – NantHealth, Inc.
- Saturday, October 2, 2021
9:05 AM – 9:50 AM EDT
Integration of Genetic Testing and Counseling Into Cancer Care
9:05 AM – 9:50 AM EDT
Integration of Genetic Testing and Counseling Into Cancer CarePresenter: – UCLA
Presenter: – Fox Chase Cancer Center
Beth Karlan, MD – UCLA ### 1367338###Presenter###Professor###UCLA###Presenter: – UCLA
@@@ Mary B. Daly, MD, PhD – Fox Chase Cancer Center ### 1376589###Presenter###Full Professor###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
10:05 AM – 11:05 AM EDT
Innovation Theater- BRUKINSA® (zanubrutinib) for the Treatment of Adult Patients with Waldenström’s Macroglobulinemia (WM) (non-accredited)
10:05 AM – 11:05 AM EDT
Innovation Theater - BRUKINSA® (zanubrutinib) for the Treatment of Adult Patients with Waldenström’s Macroglobulinemia (WM) (non-accredited)
11:20 AM – 11:50 PM EDT
Ask the Experts
11:20 AM – 11:50 PM EDT
Ask the Experts Presenter: – Roswell Park Comprehensive Cancer Center
Stephen B. Edge, MD, FACS, FASCO – Roswell Park Comprehensive Cancer Center ### 736514###Presenter###VP Healthcare Outcomes and Policy###Roswell Park Comprehensive Cancer Center###Presenter: – Roswell Park Comprehensive Cancer Center
12:05 PM – 12:50 PM EDT
Patient Centered Design of Pathways
12:05 PM – 12:50 PM EDT
Patient Centered Design of PathwaysPresenter: – Kaiser Permanente
Presenter: – Kaiser Permanente
Presenter: – Kaiser Permanente
Mishellene Mckinney, MHA, RN, OCN – Kaiser Permanente ### 1350705###Presenter###Vice President, Cancer Care Services###Kaiser Permanente###Presenter: – Kaiser Permanente
@@@ Jerilyn Crain – Kaiser Permanente ### 1394221###Presenter###Patient Partner###Kaiser Permanente###Presenter: – Kaiser Permanente
@@@ Alfonso Gomez – Kaiser Permanente ### 1394222###Presenter###Patient Partner###Kaiser Permanente###Presenter: – Kaiser Permanente
1:05 PM – 1:50 PM EDT
The Utility of Novel Therapies in CLL/SLL Clinical Pathways: Opportunities to Facilitate Treatment Selection and Sequencing
1:05 PM – 1:50 PM EDT
The Utility of Novel Therapies in CLL/SLL Clinical Pathways: Opportunities to Facilitate Treatment Selection and SequencingPresenter: – The University of Texas M.D. Anderson Cancer Center
William Wierda, MD – The University of Texas M.D. Anderson Cancer Center ### 1187153###Presenter###D.B. Lane Cancer Research Distinguished Professor###The University of Texas M.D. Anderson Cancer Center###Presenter: – The University of Texas M.D. Anderson Cancer Center
2:05 PM – 2:50 PM EDT
Pathways to Guide Appropriate and Safe Cancer Pain Management
2:05 PM – 2:50 PM EDT
Pathways to Guide Appropriate and Safe Cancer Pain ManagementPresenter: – Seattle Cancer Care Alliance
Dermot R. Fitzgibbon, MD – Seattle Cancer Care Alliance ### 1393270###Presenter###Attending Physician###Seattle Cancer Care Alliance###Presenter: – Seattle Cancer Care Alliance
3:05 PM – 3:35 PM EDT
Ask the Experts
3:05 PM – 3:35 PM EDT
Ask the Experts Presenter: – National Comprehensive Cancer Network
Wui-Jin Koh, MD – National Comprehensive Cancer Network ### 720330###Presenter###Senior Vice President and Chief Medical Officer###National Comprehensive Cancer Network###Presenter: – National Comprehensive Cancer Network
3:35 PM – 3:50 PM EDT
Exhibit Hall Break
3:35 PM – 3:50 PM EDT
Exhibit Hall Break
3:50 PM – 4:35 PM EDT
Advancing the Management of Small Cell Lung Cancer: Considerations for Clinical Pathways
3:50 PM – 4:35 PM EDT
Advancing the Management of Small Cell Lung Cancer: Considerations for Clinical Pathways Presenter: – Smilow Cancer Hospital
Anne Chiang, MD, PhD – Smilow Cancer Hospital ### 1384732###Presenter### Chief Integration Officer, Deputy Chief Medical Officer###Smilow Cancer Hospital###Presenter: – Smilow Cancer Hospital
4:50 PM – 5:35 PM EDT
Patient Reported Outcomes: Redefining the Way Patients Manage their Symptoms
4:50 PM – 5:35 PM EDT
Patient Reported Outcomes: Redefining the Way Patients Manage their Symptoms Presenter: – Dana-Farber Cancer Institute
Michael Hassett, MD, MPH – Dana-Farber Cancer Institute ### 761338###Presenter###Attending Physician###Dana-Farber Cancer Institute###Presenter: – Dana-Farber Cancer Institute
- Sunday, October 3, 2021
9:05 AM – 9:50 AM EDT
Provider & Payer Perspective on Pathway Adoption & Scale
9:05 AM – 9:50 AM EDT
Provider & Payer Perspective on Pathway Adoption & ScalePresenter: – UnitedHealth Group
Presenter: – Harvard Business School
Jennifer Malin, MD, PhD – UnitedHealth Group ### 1367347###Presenter###SVP and CMO###UnitedHealth Group###Presenter: – UnitedHealth Group
@@@ Mahek A. Shah, MD – Harvard Business School ### 736511###Presenter###Physician Executive and Advisor###Harvard Business School###Presenter: – Harvard Business School
10:05 AM – 11:05 AM EDT
Innovation Theater - Learn More About an FDA-Approved Treatment for Metastatic Triple-Negative Breast Cancer- (non-accredited)
10:05 AM – 11:05 AM EDT
Innovation Theater - Learn More About an FDA-Approved Treatment for Metastatic Triple-Negative Breast Cancer- (non-accredited)
11:05 AM – 11:20 AM EDT
Exhibit Hall Break
11:05 AM – 11:20 AM EDT
Exhibit Hall Break
11:20 AM – 11:50 PM EDT
Ask the Experts
11:20 AM – 11:50 PM EDT
Ask the Experts Presenter: – National Cancer Treatment Alliance/Community Oncology Alliance
Frederick M. Schnell, MD, FACP, MD, FACP – National Cancer Treatment Alliance/Community Oncology Alliance ### 1013729###Presenter###Chief Medical Officer###National Cancer Treatment Alliance/Community Oncology Alliance###Presenter: – National Cancer Treatment Alliance/Community Oncology Alliance
11:50 AM – 12:05 PM EDT
Exhibit Hall Break
11:50 AM – 12:05 PM EDT
Exhibit Hall Break
12:05 PM – 12:50 PM EDT
Getting on the Path Toward a Successful Oncology Pathways Program
12:05 PM – 12:50 PM EDT
Getting on the Path Toward a Successful Oncology Pathways ProgramPresenter: – Sidney Kimmel Cancer Center at Jefferson Health
Valerie P. Csik, MPH, CPPS – Sidney Kimmel Cancer Center at Jefferson Health ### 1367351###Presenter###Director of Quality and Care Transformation###Sidney Kimmel Cancer Center at Jefferson Health###Presenter: – Sidney Kimmel Cancer Center at Jefferson Health
1:05 PM – 1:50 PM EDT
Urothelial Cancer: The Role of Clinical Care Pathways in Navigating the Expanding Treatment Landscape
1:05 PM – 1:50 PM EDT
Urothelial Cancer: The Role of Clinical Care Pathways in Navigating the Expanding Treatment LandscapePresenter: – West Cancer Center and Research Institute
Daniel Vaena, MD – West Cancer Center and Research Institute ### 1139208###Presenter###Director Genitourinary and Phase 1 Programs###West Cancer Center and Research Institute###Presenter: – West Cancer Center and Research Institute
2:05 PM – 2:50 PM EDT
The View on Pathways: The Global Lens
2:05 PM – 2:50 PM EDT
The View on Pathways: The Global LensPresenter: – Harvard Business School
Presenter: – Roche
Mahek A. Shah, MD – Harvard Business School ### 736511###Presenter###Physician Executive and Advisor###Harvard Business School###Presenter: – Harvard Business School
@@@ Silvana Arenillas, MBA, MHA – Roche ### 1466349###Presenter###Strategic Market Access Manager###Roche###Presenter: – Roche
3:05 PM – 4:05 PM EDT
Innovation Theater - Preliminary Findings From the 2021 Care Pathways Working Group (non-accredited)
3:05 PM – 4:05 PM EDT
Innovation Theater - Preliminary Findings From the 2021 Care Pathways Working Group (non-accredited)
4:05 PM – 4:20 PM EDT
Exhibit Hall Break
4:05 PM – 4:20 PM EDT
Exhibit Hall Break
4:05 PM – 5:05 PM EDT
Ask the Experts
4:20 PM – 4:50 PM EDT
Ask the Experts Presenter: – Patient Advocate Foundation
Alan Balch, PhD – Patient Advocate Foundation ### 736519###Presenter###CEO###Patient Advocate Foundation###Presenter: – Patient Advocate Foundation
4:50 PM – 5:05 PM EDT
Exhibit Hall Break
4:50 PM – 5:05 PM EDT
Exhibit Hall Break
5:05 PM – 5:50 PM EDT
Promoting Evidence-Based and Cost-Effective Treatment of Metastatic Breast Cancer with Clinical Pathways
5:05 PM – 5:50 PM EDT
Promoting Evidence-Based and Cost-Effective Treatment of Metastatic Breast Cancer with Clinical PathwaysPresenter: – City of Hope National Cancer Center
Sayeh Lavasani, MD, MS – City of Hope National Cancer Center ### 1460573###Presenter###Breast Medical Oncologist###City of Hope National Cancer Center###Presenter: – City of Hope National Cancer Center
6:05 PM – 6:50 PM EDT
Oncology Clinical Pathways Congress Town Hall
6:05 PM – 6:50 PM EDT
Oncology Clinical Pathways Congress Town HallPresenter: – Roswell Park Comprehensive Cancer Center
Presenter: – Harvard Business School
Presenter: – National Comprehensive Cancer Network
Presenter: – Patient Advocate Foundation
Presenter: – National Cancer Treatment Alliance/Community Oncology Alliance
Presenter: – Michiana Hematology-Oncology, PC
Stephen B. Edge, MD, FACS, FASCO – Roswell Park Comprehensive Cancer Center ### 736514###Presenter###VP Healthcare Outcomes and Policy###Roswell Park Comprehensive Cancer Center###Presenter: – Roswell Park Comprehensive Cancer Center
@@@ Mahek A. Shah, MD – Harvard Business School ### 736511###Presenter###Physician Executive and Advisor###Harvard Business School###Presenter: – Harvard Business School
@@@ Wui-Jin Koh, MD – National Comprehensive Cancer Network ### 720330###Presenter###Senior Vice President and Chief Medical Officer###National Comprehensive Cancer Network###Presenter: – National Comprehensive Cancer Network
@@@ Alan Balch, PhD – Patient Advocate Foundation ### 736519###Presenter###CEO###Patient Advocate Foundation###Presenter: – Patient Advocate Foundation
@@@ Frederick M. Schnell, MD, FACP, MD, FACP – National Cancer Treatment Alliance/Community Oncology Alliance ### 1013729###Presenter###Chief Medical Officer###National Cancer Treatment Alliance/Community Oncology Alliance###Presenter: – National Cancer Treatment Alliance/Community Oncology Alliance
@@@ Robin Zon, MD, FACP – Michiana Hematology-Oncology, PC ### 736521###Presenter###President###Michiana Hematology-Oncology, PC###Presenter: – Michiana Hematology-Oncology, PC
